Evidence map›Paper›PMID 24858279›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2014

Lamin B1 overexpression increases nuclear rigidity in autosomal dominant leukodystrophy fibroblasts.

Denise Ferrera, Claudio Canale, Roberto Marotta, Nadia Mazzaro, Marta Gritti, Michele Mazzanti, Sabina Capellari, Pietro Cortelli, Laura Gasparini

Open access · hybridAbstract readComparative Study
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 84 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Case report:Frontiers in neuroscience · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Mechanics and functional consequences of nuclear deformations.Nature reviews. Molecular cell biology · 2022
    Review
  12. Review
  13. Review
  14. Emerging cellular themes in leukodystrophies.Frontiers in cell and developmental biology · 2022
    Review
  15. The LEM-ESCRT toolkit: Repair and maintenance of the nucleus.Frontiers in cell and developmental biology · 2022
    Review
  16. Review
  17. Review
  18. Regulation of Nuclear Mechanics and the Impact on DNA Damage.International journal of molecular sciences · 2021
    Review
  19. Disease Modeling with Human Neurons Reveals LMNB1 Dysregulation Underlying DYT1 Dystonia.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Denise FerreraDepartment of Neuroscience and Brain Technologies.
Claudio CanaleDepartment of Nanophysics, and.
Roberto MarottaDepartment of Nanochemistry, Istituto Italiano di Tecnologia, Genoa, Italy;
Nadia MazzaroDepartment of Neuroscience and Brain Technologies.
Marta GrittiDepartment of Biosciences, University of Milano, Milan, Italy;
Michele MazzantiDepartment of Biosciences, University of Milano, Milan, Italy;
Sabina CapellariIstituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto delle Scienze Neurologiche di Bologna, Clinica Neurologica, Ospedale Bellaria, Bologna, Italy; and Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
Pietro CortelliIstituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto delle Scienze Neurologiche di Bologna, Clinica Neurologica, Ospedale Bellaria, Bologna, Italy; and Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
Laura GaspariniDepartment of Neuroscience and Brain Technologies, laura.gasparini@iit.it.
Italian Institute of Technology · ITUniversity of Bologna · ITUniversity of Milan · IT

Funding

Telethon GGP10184
6 · The paper itself

Abstract

The architecture and structural mechanics of the cell nucleus are defined by the nuclear lamina, which is formed by A- and B-type lamins. Recently, gene duplication and protein overexpression of lamin B1 (LB1) have been reported in pedigrees with autosomal dominant leukodystrophy (ADLD). However, how the overexpression of LB1 affects nuclear mechanics and function and how it may result in pathology remain unexplored. Here, we report that in primary human skin fibroblasts derived from ADLD patients, LB1, but not other lamins, is overexpressed at the nuclear lamina and specifically enhances nuclear stiffness. Transient transfection of LB1 in HEK293 and neuronal N2a cells mimics the mechanical phenotype of ADLD nuclei. Notably, in ADLD fibroblasts, reducing LB1 protein levels by shRNA knockdown restores elasticity values to those indistinguishable from control fibroblasts. Moreover, isolated nuclei from ADLD fibroblasts display a reduced nuclear ion channel open probability on voltage-step application, suggesting that biophysical changes induced by LB1 overexpression may alter nuclear signaling cascades in somatic cells. Overall, the overexpression of LB1 in ADLD cells alters nuclear mechanics and is linked to changes in nuclear signaling, which could help explain the pathogenesis of this disease.

Indexed as

AdultAnimalsBlotting, WesternCase-Control StudiesCell Membrane PermeabilityCell NucleusCell ProliferationCells, CulturedEmbryo, MammalianFemaleFibroblastsFlow CytometryFluorescent Antibody TechniqueHumansLamin Type BMaleLamin Type BRNA, Small InterferingADLDatomic force microscopyhuman fibroblastsnuclear laminanucleus

Identifiers

PMID24858279
PMCPMC4139899
OpenAlexW2086020778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.